3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelomonocytic, Acute
4
Leukemia, Myeloid, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Lymphoma, Non-Hodgkin
3
Wilms Tumor
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Melanoma
2
Medulloblastoma
2
Leukemia, Myelomonocytic, Chronic
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Congenital Abnormalities
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Xanthogranuloma, Juvenile
1
Interventions
Mycophenolic Acid
17
fludarabine phosphate
16
Cyclophosphamide
15
Whole-Body Irradiation
10
Tacrolimus
10
Melphalan
10
Peripheral Blood Stem Cell Transplantation
9
Filgrastim
9
Cyclosporine
9
Busulfan
9
Antilymphocyte Serum
8
Granulocyte Colony-Stimulating Factor
7
thymoglobulin
6
Methotrexate
6
Cord Blood Stem Cell Transplantation
5
fludarabine
4
Thiotepa
4
Radiotherapy
4
Methylprednisolone
4
Etoposide
4
Cytarabine
4
Stem Cell Transplantation
3
Rituximab
3
Clofarabine
3
Transplantation
2
Sirolimus
2
Methylprednisolone Hemisuccinate
2
Methylprednisolone Acetate
2
Etanercept
2
Alemtuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myelomonocytic, Juvenile
×
tipifarnib
×
Clear all
No trials found.